Cargando…
Treatment-related toxicities of apatinib in solid tumors: a meta-analysis
BACKGROUND: Apatinib is a novel small molecular drug targeting vascular endothelial growth factor receptor-2 (VEGFR-2), which is being studied in multiple tumor types. We performed a meta-analysis to quantify the overall incidence and risk of hypertension, proteinuria, and hand-foot-syndrome (HFS) i...
Autores principales: | Peng, Ling, Ye, Xianghua, Hong, Yun, Zhang, Junyan, Dong, Yongquan, Zhao, Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114950/ https://www.ncbi.nlm.nih.gov/pubmed/30181815 http://dx.doi.org/10.18632/oncotarget.24215 |
Ejemplares similares
-
Incidence and relative risk of peripheral neuropathy in cancer patients treated with eribulin: a meta-analysis
por: Peng, Ling, et al.
Publicado: (2017) -
Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis
por: Peng, Ling, et al.
Publicado: (2017) -
Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes
por: Liu, Jian, et al.
Publicado: (2017) -
APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis
por: Yuan, Chun-Ling, et al.
Publicado: (2017) -
The prognostic value of p62 in solid tumor patients: a meta-analysis
por: Ruan, Haihua, et al.
Publicado: (2017)